Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation
2020268 citationsLing Peng, Wen Li et al.Cell Death and Diseaseprofile →
Citations per year, relative to Cheng-ping Hu Cheng-ping Hu (= 1×)
peers
Changming Wang
Countries citing papers authored by Cheng-ping Hu
Since
Specialization
Citations
This map shows the geographic impact of Cheng-ping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-ping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-ping Hu more than expected).
This network shows the impact of papers produced by Cheng-ping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-ping Hu. The network helps show where Cheng-ping Hu may publish in the future.
Co-authorship network of co-authors of Cheng-ping Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-ping Hu.
A scholar is included among the top collaborators of Cheng-ping Hu based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Cheng-ping Hu. Cheng-ping Hu is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Hu, Cheng-ping & Min Li. (2012). [An overview of female non-small cell lung cancer].. PubMed. 35(2). 89–90.2 indexed citations
5.
Xiong, Zeng, et al.. (2011). [Relationship between multi-slice spiral CT pulmonary perfusion imaging and the expression of EphB4 and ephrinB2 in non-small cell lung cancer].. PubMed. 33(3). 192–6.1 indexed citations
6.
Deng, Pengbo, et al.. (2011). [Misdiagnosis of pancoast cancer: analysis of 26 cases].. PubMed. 34(9). 663–5.3 indexed citations
7.
Zhu, Xiaoxia, et al.. (2010). [CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women].. PubMed. 33(11). 817–22.15 indexed citations
8.
Li, Yuanyuan, et al.. (2009). [The diagnostic value of flexible bronchoscopy in tracheobronchopathia osteochondroplastica].. PubMed. 32(7). 489–92.6 indexed citations
9.
Hu, Cheng-ping, et al.. (2009). [A novel mutation of the SLC34A2 gene in a Chinese pedigree with pulmonary alveolar microlithiasis].. PubMed. 26(4). 365–8.11 indexed citations
10.
Hu, Cheng-ping, et al.. (2007). [Effect of ginsenoside Rh2 on immunocompetence of alveolar macrophages in patients with non-small cell lung cancer].. PubMed. 32(5). 868–72.6 indexed citations
11.
Chen, Qiong, et al.. (2007). [Study on the relationship between the polymorphism of p53 gene intron 7 and non-small cell lung cancer (NSCLC) and p53 mutation in NSCLC tissues].. PubMed. 24(3). 319–21.2 indexed citations
12.
Hu, Shuo, et al.. (2005). [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].. PubMed. 85(21). 1493–8.3 indexed citations
13.
Xie, Wei, et al.. (2004). [Pathogens and drug resistance of nosocomial pneumonia after intracranial surgery].. PubMed. 29(4). 435–7.1 indexed citations
14.
Ouyang, Quchang, Cheng-ping Hu, & Qinghua Liang. (2003). [Gene expression of MMP1 and TIMP1 in lung cancer detected with a cDNA microarray technique].. PubMed. 28(3). 227–8.3 indexed citations
15.
Hu, Cheng-ping, et al.. (2003). [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].. PubMed. 28(6). 608–10.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.